Development of a Robotic Ankle Assist Device
Key facts
- Who runs it
- BiOMOTUM, Inc.
- Where
- Flagstaff, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Phase 1
- People taking part
- 31 people enrolled
- Started
- 1 Nov 2020
- Ended
- 31 Aug 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- Robotic Ankle Assist Device (RAAD)
- Record updated
- 4 April 2025
Who can take part
- Age
- 8 years to 21 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Diagnosis of cerebral palsy. Any sex, race, ethnicity or socioeconomic status. GMFCS level I, II, or II. Ability to walk for at least 6 minutes (assisted or unassisted). Age between 8-18 years. Height/weight/BMI between the 5th - 95th percentile of children with CP
- Able to understand and follow simple directions. Able to complete 5 heel raises with minimal assistance (balance only). At least 20 degrees of passive ankle plantar flexion range of motion
Who cannot take part
- Orthopedic surgery completed in the prior 12-months. Current enrollment in a conflicting research study
- Knee extension or ankle dorsiflexion contractures greater than 15 degrees. Health condition or diagnosis other than CP that would affect safe participation
Where in United States
- Northern Arizona UniversityFlagstaff, United States
About the trial
What the trial wants to find out
The overall objectives of this work is to establish feasibility of a robotic ankle assist device (RAAD) to improve mobility in free-living settings and to establish the RAAD as an effective tool to provide increased dose and precision of targeted ankle therapy.
Read full original descriptionShow less
The first specific goal is to assess the benefits of repeated gait training with RAAD assistance. Individuals with CP will participate in a 4-week assistance intervention and mobility outcomes will be quantified pre and post intervention.
The second specific goal is to separately assess the benefits of repeated gait training with RAAD resistance. Individuals with CP will participate in a 4-week resistance intervention and mobility outcomes will be quantified pre and post intervention.
Assessed separately, it is hypothesized that both assistance and resistance training will improve mobility outcomes.
The 2 groups in the trial
- Therapist supervised assistance trainingTreatment being tested
Assistance training with the RAAD under therapist supervision.
Treatment: Robotic Ankle Assist Device (RAAD)
- Therapist supervised resistance trainingTreatment being tested
Resistance training with the RAAD under therapist supervision.
Treatment: Robotic Ankle Assist Device (RAAD)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Development of a Robotic Ankle Assist Device to Improve Mobility in Individuals With Movement Disorders
- Record updated
- 4 April 2025